Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Julia Schiffner-Rohe"'
Autor:
Matthias Horn, Christian Theilacker, Ralf Sprenger, Christof von Eiff, Ernestine Mahar, Julia Schiffner-Rohe, Mathias W. Pletz, Mark van der Linden, Markus Scholz
Publikováno v:
PLoS ONE, Vol 18, Iss 2 (2023)
Introduction Two next-generation pneumococcal conjugate vaccines (PCVs), a 15- and a 20-valent PCV (PCV15 and PCV20), have recently been licensed for use in adults, and PCV15 has also been licensed in children. We developed a dynamic transmission mod
Externí odkaz:
https://doaj.org/article/0871ec134c284d7aa824648d416efb01
Autor:
Ralf Sprenger, Dennis Häckl, Nils Kossack, Julia Schiffner-Rohe, Jessica Wohlleben, Christof von Eiff
Publikováno v:
PLoS ONE, Vol 17, Iss 3 (2022)
Background Pneumococcal vaccination is recommended by the German Standing Committee on Vaccination (STIKO) for infants, elderly 60+ years and patients at risk. In 2016, a sequential pneumococcal vaccination schedule (conjugate vaccine followed by pol
Externí odkaz:
https://doaj.org/article/eab32859109b4d1881cda14e130d1b9f
Autor:
Christian Theilacker, Ralf Sprenger, Friedhelm Leverkus, Jochen Walker, Dennis Häckl, Christof von Eiff, Julia Schiffner-Rohe
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0253118 (2021)
BackgroundLittle information on the current burden of community-acquired pneumonia (CAP) in adults in Germany is available.MethodsWe conducted a retrospective cohort study using a representative healthcare claims database of approx. 4 million adults
Externí odkaz:
https://doaj.org/article/b359d73b5d6b4076aba8f3a99df753e2
Autor:
Niklas Schmedt, Julia Schiffner-Rohe, Ralf Sprenger, Jochen Walker, Christof von Eiff, Dennis Häckl
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0220848 (2019)
BackgroundThe German Committee on Vaccination recommends pneumococcal vaccination for infants, seniors 60+ years and patients at risk with defined underlying diseases. Aim of this study was to assess the pneumococcal vaccination rate (pnc-VR) in pati
Externí odkaz:
https://doaj.org/article/c406e270ac984d90a8642a0bbdcb6219
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0197905 (2018)
INTRODUCTION:In Germany, a 23-valent polysaccharide pneumococcal vaccine (PPSV23) is recommended for elderly (60+) and patients 16+ with chronic diseases not associated with immune suppression. For all other patients at risk, sequential immunization
Externí odkaz:
https://doaj.org/article/831c0bf2917e420daa5af52b768504ac
Autor:
Julia Schiffner-Rohe, Annika Witt, Jana Hemmerling, Christof von Eiff, Friedrich-Wilhelm Leverkus
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0146338 (2016)
BACKGROUND:Pneumococcal community-acquired pneumonia (pCAP) is the most frequent form of pneumonia. The elderly and adults with underlying diseases are at an increased risk of developing pCAP. The 23-valent pneumococcal polysaccharide vaccine (PPV23)
Externí odkaz:
https://doaj.org/article/39093c3858784602b42a908f9725b9e9
Autor:
Matthias Horn, Christian Theilacker, Ralf Sprenger, Christof von Eiff, Ernestine Mahar, Julia Schiffner-Rohe, Mathias W. Pletz, Mark PG van der Linden, Markus Scholz
Publikováno v:
SSRN Electronic Journal.
Autor:
Ralf Sprenger, Dennis Häckl, Nils Kossack, Julia Schiffner-Rohe, Jessica Wohlleben, Christof von Eiff
Publikováno v:
PloS one. 17(3)
Background Pneumococcal vaccination is recommended by the German Standing Committee on Vaccination (STIKO) for infants, elderly 60+ years and patients at risk. In 2016, a sequential pneumococcal vaccination schedule (conjugate vaccine followed by pol
Publikováno v:
European journal of dermatology : EJD. 13(3)
Clear proceedings in detection of malignant melanoma and monitoring of melanocytic nevi (MN) have been achieved by dermoscopy in recent years: sensitivity to 95% is possible for experts. Does patients' confidence in methods for detection of malignant
Autor:
Roman, Schiffner, Julia, Schiffner-Rohe, Marco, Gerstenhauer, Michael, Landthaler, Ferdinand, Hofstädter, Wilhelm, Stolz
Publikováno v:
European journal of dermatology : EJD. 12(6)
Safety and efficacy of this new treatment modality for out-patients were evaluated by an uncontrolled multicenter trial under GCP-conditions. Patients had to undergo 3-5 treatment sessions per week up to 35 in total. SCORAD (SC) was assessed at basel